🕐07.12.11 - 18:54 Uhr

MID-DAY BREAKING NEWS FROM NORTHERN LION, NORTHERN VERTEX, COLOMBIA CREST, PACIF
IC THERAPEUTICS, AND STELLAR BIOTECHNOLOGIES



Add to your address book or safe list to ensure delivery of email blasts (click for instructions)


Get Real-Time Quote
Northern Lion Launches Airborne Geophysical Survey Over Underexplored Western Permits, Republic of Cyprus
07 Dec 2011
Northern Lion Gold Corp. wishes to announce the commencement of the airborne geophysical survey covering the Companys western permits in the Republic of Cyprus.The Company has contracted Geotech Airborne Malta, Limited to carry out a helicopter-borne Versatile Time-Domain Electromagnetic geophysical survey at 100 metre line spacing for a total of 850 line kilometres and will cover 80 square kilometres. [View More]

Get Real-Time Quote
Northern Vertex Commences 12-Hole, Phase II Drilling Program on Copley Gold Property in British Columbias Nechako Plateau
07 Dec 2011
Northern Vertex Capital Inc. is pleased to announce the commencement of a phase II drill program on its Copley gold property situated south of Fraser Lake in British Columbias Nechako Plateau. An estimated total of 12 drill holes will test the extension of a previously drilled 33 m intersection that returned grades of 0.271 g/t Au in hole 01-04. Of the 33 m: 5.6 m averaged 0.68 g/t Au, and 1.4 m averaged 1.57 g/t Au. [View More]

Get Real-Time Quote
Colombia Crest Gold Discovers a Second Anomalous Gold Zone; Applies for Drill Permits in the Arabia Area, Colombia
07 Dec 2011
Colombia Crest Gold Corp. is pleased to announce that an additional area of anomalous gold in soil was defined by the soil sample results at the Arabia Porphyry Gold-Copper Target, Antioquia Province, Colombia. Assay results from all 1132 soil samples have now been received. Anomalous gold values are those greater than 40 parts per billion ("ppb"). [View More]

Get Real-Time Quote
Pacific Therapeutics Ltd. Announces Filing of Monthly Report on CNSX Web Site
07 Dec 2011
Pacific Therapeutics Ltd. is a development stage specialty pharmaceutical company focused on the identification and development of drug candidates to treat diseases of excessive scarring. Mr. Doug Unwin, President and CEO of the Issuer, is pleased to announce the filing of the Issuers first monthly report on the Canadian National Stock Exchange web site . [View More]

Get Real-Time Quote
Stellar Biotechnologies Announces Significant Expansion of Keyhole Limpet Hatchery & Sera Production Capability
07 Dec 2011
Stellar Biotechnologies, Inc. is pleased to announce the completion of a major expansion of its keyhole limpet (megathura crenulata) hatchery facility in Port Hueneme, CA in anticipation of increases in demand for its keyhole limpet hemocyanin (KLH) products. [View More] VIEW MORE [+]

Disclaimer: Vantage Communications Ltd. was paid to distribute this bulletin. Vantage Communications may or may not own securities in this particular company. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! You are on this mailing list because you registered for VantageWire News. Past performance of Companies mentioned does not guarantee future performance.

If you would like to opt out click here.

For more information about this service, please contact:
Vantage Communications Ltd. at 1.800.574.0901, Suite 150 - 666 Burrard St, Vancouver, British Columbia V6C 2X8, This email complies with the US Federal CAN-SPAM Act of 2003




Products & Services | Jobs